Ambea as an investment
- Growing need
- Strong market position
- High quality and competence
- Substantial growth
- Balanced risk
- Attractive capital allocation
The share
Key figures FY 2025
16,039 MSEK
Net sales
1,535 MSEK
Adjusted EBITA
13%
Growth
9.6%
EBITA margin
News and press releases
Calendar
- Oct 22026-10-02 08:00Silent period
- Nov 42026-11-04 08:00Q3 roadshow, Nordea, Stockholm
- Nov 172026-11-17 08:00Jefferies Global Healthcare Conference, London
- Feb 112027-02-11 07:00Year-end report 2026
Reports
Interim report January–September 2026
The quarter was both strong and highly eventful for Ambea. We are now ready to combine Ambea and Humana, two complementary care companies with
a shared commitment to quality, responsibility and a long-term approach.
Annual report: Future-proof care in a changing society
Annual report with quality & sustainability report 2025
Mark Jensen about the interim report January–September 2026
CEO Mark Jensen presents the report from Stendi Alnagata and Bekkensten in Oslo.
IR Contact
Susanne Vogt
Head of IR, Reporting & Group Business Control
No matching results.
